DZ Bank’s AbbVie ABBV Stock Holding History

DZ Bank’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,980,000	Closed	-$389M	–	936
2024 Q3	$389M	Buy	+1,980,000	New	+$370M	0.38%	71
2024 Q2	–	Sell	-2,656,500	Closed	-$483M	–	1024
2024 Q1	$483M	Hold	2,656,500	–	–	0.52%	48
2023 Q4	$409M	Hold	2,656,500	–	–	0.51%	52
2023 Q3	$397M	Hold	2,656,500	–	–	0.56%	45
2023 Q2	$358M	Hold	2,656,500	–	–	0.54%	48
2023 Q1	$421M	Buy	+2,656,500	New	+$406M	0.69%	39
2018 Q4	–	Sell	-16,000	Closed	-$1.51M	–	747
2018 Q3	$1.51M	Buy	+16,000	New	+$1.52M	0.01%	479

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DZ Bank's ABBV Position: Q1 2026 in Review

DZ Bank reduced its AbbVie (ABBV) stake by 88% in Q1 2026, selling an estimated $1.74B and leaving 1,091,285 shares worth $237M. The position accounts for 0.21% of the portfolio, ranked #94.

DZ Bank first reported a position in ABBV in Q4 2016 and has held it in 38 quarters since. The position peaked at $2.04B in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

DZ Bank held 1,091,285 shares of AbbVie worth $237M as of Q1 2026.
DZ Bank sold 7,827,781 AbbVie shares in Q1 2026, an estimated $1.74B.
AbbVie made up 0.21% of DZ Bank's portfolio in Q1 2026, its #94 holding.
DZ Bank first reported a position in AbbVie in Q4 2016 and has held it in 38 quarters since.
DZ Bank's AbbVie position peaked at $2.04B in Q4 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on DZ Bank's 13F filing for Q1 2026, filed 15 May 2026.